| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |